Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
sales of 48.55 billion Swiss Francs [US$48.46 billion]
of which 60%
(34.86 billion Euro [US$37.36 billion]
of which 85%
was Pharmaceuticals), and
based in Germany
(46.32 billion Euro [US$49.65 billion]
of which 30%
was Pharmaceuticals & Biological Products).
Roche Holding Aktiengesellschaft reported sales of 48.15 billion Swiss Francs (US$48.05 billion)
December of 2015.
a very small
increase of 1.4%
versus 2014, when the company's sales were 47.46 billion Swiss Francs.
This was the fourth straight year of sales growth at Roche Holding Aktiengesellschaft.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Roche Holding Aktiengesellschaft had sales
of 47.47 billion Swiss Francs.
Sales of Pharmaceuticals saw an increase
1.7% in 2015, from
36.70 billion Swiss Francs to 37.33 billion Swiss Francs.